Charles River Laboratories Announces Second-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Charles River Laboratories (CRL) Tops Q2 EPS by 23c; Raises Guidance
August 4, 2021 7:08 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.61, $0.23 better than the analyst estimate of $2.38. Revenue for the quarter came in at $914.6 million versus the consensus estimate of $880.65 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, The strength of our leading, non-clinical... More
